$NWBO
NORTHWEST BIOTHERAPEUTICS INC

2020 Q3 Form 10-Q Financial Statement

#000110465921004396 Filed on January 15, 2021

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $216.0K $593.0K $581.0K
YoY Change -63.58% 30.91% 108.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $30.43M $3.640M $3.927M
YoY Change 736.07% -33.53% -74.42%
% of Gross Profit
Research & Development $17.66M $3.538M $3.291M
YoY Change 399.15% -17.64% -37.69%
% of Gross Profit
Depreciation & Amortization $17.00K $8.000K $6.000K
YoY Change 112.5% -97.65% -98.32%
% of Gross Profit
Operating Expenses $17.66M $3.538M $3.291M
YoY Change 399.15% -17.64% -37.69%
Operating Profit -$47.88M -$6.585M -$6.637M
YoY Change 627.06% -29.34% -67.39%
Interest Expense $5.540M $724.0K $787.0K
YoY Change 665.19% -54.64% -76.17%
% of Operating Profit
Other Income/Expense, Net -$146.2M $214.0K $6.856M
YoY Change -68426.64%
Pretax Income -$194.1M -$6.371M $219.0K
YoY Change 2946.55% -150.65% -101.03%
Income Tax
% Of Pretax Income
Net Earnings -$194.1M -$6.371M $219.0K
YoY Change 2946.55% -150.65% -101.03%
Net Earnings / Revenue -89859.26% -1074.37% 37.69%
Basic Earnings Per Share -$0.26 $0.00
Diluted Earnings Per Share -$0.26 -$11.04K $0.00
COMMON SHARES
Basic Shares Outstanding 747.7K 577.1K 550.2K
Diluted Shares Outstanding 747.7K 597.4K

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.250M $1.970M $6.676M
YoY Change 369.54% 694.35% 317.25%
Cash & Equivalents $9.250M $1.970M $6.676M
Short-Term Investments
Other Short-Term Assets $2.933M $2.602M $2.230M
YoY Change 12.72% 199.08% 165.48%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.18M $4.572M $8.906M
YoY Change 166.47% 308.94% 265.75%
LONG-TERM ASSETS
Property, Plant & Equipment $819.0K $4.820M $5.023M
YoY Change -83.01% -89.32% -89.08%
Goodwill $654.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $803.0K $753.0K $775.0K
YoY Change 6.64% 1023.88% 1170.49%
Total Long-Term Assets $15.03M $5.573M $5.798M
YoY Change 169.69% -87.67% -87.41%
TOTAL ASSETS
Total Short-Term Assets $12.18M $4.572M $8.906M
Total Long-Term Assets $15.03M $5.573M $5.798M
Total Assets $27.21M $10.15M $14.70M
YoY Change 168.24% -78.1% -69.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.10M $7.397M $6.435M
YoY Change 90.55% -71.23% -68.99%
Accrued Expenses $240.0K $291.0K $280.0K
YoY Change -17.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $8.599M
YoY Change -100.0%
Long-Term Debt Due $10.17M $7.003M
YoY Change 45.17%
Total Short-Term Liabilities $226.3M $53.42M $55.46M
YoY Change 323.56% -30.87% -43.72%
LONG-TERM LIABILITIES
Long-Term Debt $8.708M $6.652M $7.557M
YoY Change 30.91% -58.93% -44.92%
Other Long-Term Liabilities $4.657M $4.605M $4.690M
YoY Change 1.13%
Total Long-Term Liabilities $13.37M $11.26M $12.25M
YoY Change 18.73% -30.5% -10.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $226.3M $53.42M $55.46M
Total Long-Term Liabilities $13.37M $11.26M $12.25M
Total Liabilities $239.6M $64.68M $67.71M
YoY Change 270.5% -30.8% -39.69%
SHAREHOLDERS EQUITY
Retained Earnings -$1.091B
YoY Change
Common Stock $878.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$212.4M -$55.90M -$54.24M
YoY Change
Total Liabilities & Shareholders Equity $27.21M $10.15M $14.70M
YoY Change 168.24% -78.1% -69.67%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$194.1M -$6.371M $219.0K
YoY Change 2946.55% -150.65% -101.03%
Depreciation, Depletion And Amortization $17.00K $8.000K $6.000K
YoY Change 112.5% -97.65% -98.32%
Cash From Operating Activities -$8.022M -$6.452M -$9.678M
YoY Change 24.33% 59.39% -16.35%
INVESTING ACTIVITIES
Capital Expenditures -$2.242M -$21.00K -$61.00K
YoY Change 10576.19%
Acquisitions
YoY Change
Other Investing Activities -$1.560M
YoY Change
Cash From Investing Activities -$3.802M -$21.00K -$61.00K
YoY Change 18004.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.68M 850.0K 29.00K
YoY Change 1862.12% -58.78% -99.71%
NET CHANGE
Cash From Operating Activities -8.022M -6.452M -9.678M
Cash From Investing Activities -3.802M -21.00K -61.00K
Cash From Financing Activities 16.68M 850.0K 29.00K
Net Change In Cash 4.854M -5.623M -9.710M
YoY Change -186.32% 183.13% 471.18%
FREE CASH FLOW
Cash From Operating Activities -$8.022M -$6.452M -$9.678M
Capital Expenditures -$2.242M -$21.00K -$61.00K
Free Cash Flow -$5.780M -$6.431M -$9.617M
YoY Change -10.12% 58.87% -16.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001072379
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
NORTHWEST BIOTHERAPEUTICS INC
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
614300000
us-gaap Revenues
Revenues
788000
us-gaap Revenues
Revenues
1513000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17660000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3538000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
779700000
CY2020Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P2Y6M
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35737
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3306718
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 Montgomery Lane, Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address Country
EntityAddressCountry
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
497-9024
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12g Title
Security12gTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
NWBO
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
822716397
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9250000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
372000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2933000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2828000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
12183000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
3200000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
819000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
281000
CY2020Q3 nwbo Constructions In Progress Net
ConstructionsInProgressNet
7135000
CY2019Q4 nwbo Constructions In Progress Net
ConstructionsInProgressNet
1685000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4327000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4679000
CY2020Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1292000
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2020Q3 us-gaap Goodwill
Goodwill
654000
CY2019Q4 us-gaap Goodwill
Goodwill
0
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
803000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
798000
CY2020Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
15030000
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
7443000
CY2020Q3 us-gaap Assets
Assets
27213000
CY2019Q4 us-gaap Assets
Assets
10643000
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9171000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6348000
CY2020Q3 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
4924000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9413000
CY2020Q3 us-gaap Legal Fees
LegalFees
1112000
CY2019Q3 us-gaap Legal Fees
LegalFees
802000
us-gaap Legal Fees
LegalFees
2475000
us-gaap Legal Fees
LegalFees
3255000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24737000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10092000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29321000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2838000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36822000
CY2019Q4 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
3844000
CY2020Q3 nwbo Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
5144000
CY2019Q4 nwbo Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
568000
CY2020Q3 nwbo Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
1470000
CY2019Q4 nwbo Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
0
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
3552000
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5501000
CY2020Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2019Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
66000
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
7384000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
7261000
CY2020Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
194391000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
20213000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
240000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
395000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
226276000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44196000
CY2020Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
8708000
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
6588000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4657000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4914000
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
13365000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11502000
CY2020Q3 us-gaap Liabilities
Liabilities
239641000
CY2019Q4 us-gaap Liabilities
Liabilities
55698000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
779700000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
614300000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
780000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
614000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
877376000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
794900000
CY2020Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
26000
CY2019Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
10000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1090917000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-841395000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
359000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
836000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-212428000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-45055000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27213000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10643000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
216000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
8862000
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
13426000
nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
9626000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
11228000
nwbo Cashless Warrants Exercised
CashlessWarrantsExercised
0
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
593000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
788000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1513000
CY2020Q3 us-gaap Revenues
Revenues
216000
CY2019Q3 us-gaap Revenues
Revenues
593000
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
48093000
CY2019Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7178000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
64034000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
22760000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-47877000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6585000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63246000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21247000
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-138969000
CY2019Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2460000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-175170000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2360000
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2994000
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-504000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4260000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-508000
CY2020Q3 us-gaap Interest Expense
InterestExpense
5540000
CY2019Q3 us-gaap Interest Expense
InterestExpense
724000
us-gaap Interest Expense
InterestExpense
7224000
us-gaap Interest Expense
InterestExpense
2267000
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
1284000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1018000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
378000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-975000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-146219000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
214000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-186276000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6110000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-194096000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-6371000
us-gaap Net Income Loss
NetIncomeLoss
-249522000
us-gaap Net Income Loss
NetIncomeLoss
-27357000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1240000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-892000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
477000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1023000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-195336000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5479000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-249999000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26334000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
747749
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
577130
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
695423
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
552335
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-83005000
nwbo Adjustment To Additional Paid In Capital Reclassification Of Cashless Warrants Exercised
AdjustmentToAdditionalPaidInCapitalReclassificationOfCashlessWarrantsExercised
133000
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
44000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39307000
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
200000
CY2020Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3909000
CY2020Q3 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
8778000
CY2020Q3 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
5629000
CY2020Q3 nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
8507000
CY2020Q3 nwbo Adjustment To Additional Paid In Capital Reclassification Of Cashless Warrants Exercised
AdjustmentToAdditionalPaidInCapitalReclassificationOfCashlessWarrantsExercised
133000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16000
nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
1991000
nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
1020000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-175170000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2360000
nwbo Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
4260000
nwbo Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
508000
nwbo Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
249000
nwbo Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
435000
nwbo Stock Based Compensation Related To Warrants Modification
StockBasedCompensationRelatedToWarrantsModification
0
nwbo Stock Based Compensation Related To Warrants Modification
StockBasedCompensationRelatedToWarrantsModification
3000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
39307000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1560000
nwbo Noncash Interest Expense
NoncashInterestExpense
4270000
nwbo Noncash Interest Expense
NoncashInterestExpense
0
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
225280000
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
5902000
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-146000
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
1059000
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
12000
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
23000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
986000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
44000
CY2020Q3 nwbo Subscription Receivable Proceeds From Investor
SubscriptionReceivableProceedsFromInvestor
-5000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38908000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-194096000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1240000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-212428000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
62000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1080000
us-gaap Net Income Loss
NetIncomeLoss
-249522000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-477000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-212428000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-48131000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
200000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1210000
nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
2219000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
1759000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-54238000
CY2019Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
200000
CY2019Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1210000
CY2019Q3 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
2043000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
569000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-6371000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
892000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-55895000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-45055000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
600000
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
7020000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1560000
us-gaap Net Income Loss
NetIncomeLoss
-27357000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1023000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-55895000
us-gaap Net Income Loss
NetIncomeLoss
-249522000
us-gaap Net Income Loss
NetIncomeLoss
-27357000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
33000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-3412000
nwbo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
152000
nwbo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
6000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21890000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25881000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
3548000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
246000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1560000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5108000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-246000
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
16893000
nwbo Proceeds From Issuance Of Capital Stock And Warrants
ProceedsFromIssuanceOfCapitalStockAndWarrants
2241000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9626000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2219000
nwbo Proceeds From Warrant Modification
ProceedsFromWarrantModification
4000
nwbo Proceeds From Warrant Modification
ProceedsFromWarrantModification
7000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8557000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
6500000
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
3190000
nwbo Warrants Issued Associated With Convertible Notes Payable
WarrantsIssuedAssociatedWithConvertibleNotesPayable
0
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
315000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1556000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
420000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
64000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
329000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
89000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0
nwbo Repayment Of Convertible Notes Payable To Related Party
RepaymentOfConvertibleNotesPayableToRelatedParty
0
nwbo Repayment Of Convertible Notes Payable To Related Party
RepaymentOfConvertibleNotesPayableToRelatedParty
5400000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36876000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4818000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1055000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8878000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20254000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
372000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22224000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9250000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1970000
nwbo Unpaid Consideration Related To Acquisition Of Businesses
UnpaidConsiderationRelatedToAcquisitionOfBusinesses
465000
nwbo Unpaid Consideration Related To Acquisition Of Businesses
UnpaidConsiderationRelatedToAcquisitionOfBusinesses
0
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
11228000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
1759000
nwbo Adjustment To Additional Paid In Capital Reclassification Of Cashless Warrants Exercised
AdjustmentToAdditionalPaidInCapitalReclassificationOfCashlessWarrantsExercised
133000
nwbo Adjustment To Additional Paid In Capital Reclassification Of Cashless Warrants Exercised
AdjustmentToAdditionalPaidInCapitalReclassificationOfCashlessWarrantsExercised
0
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
6850000
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
5533000
nwbo Offering Cost Related To Warrant Liability
OfferingCostRelatedToWarrantLiability
3749000
nwbo Offering Cost Related To Warrant Liability
OfferingCostRelatedToWarrantLiability
1031000
nwbo Warrants Issued Associated With Convertible Notes Payable
WarrantsIssuedAssociatedWithConvertibleNotesPayable
153000
nwbo Warrants Issued In Connection With Debt Modification
WarrantsIssuedInConnectionWithDebtModification
395000
nwbo Warrants Issued In Connection With Debt Modification
WarrantsIssuedInConnectionWithDebtModification
0
nwbo Warrant Modification In Connection With Debt Amendment
WarrantModificationInConnectionWithDebtAmendment
91000
nwbo Warrant Modification In Connection With Debt Amendment
WarrantModificationInConnectionWithDebtAmendment
0
nwbo Adjustments To Additional Paid In Capital Beneficial Conversion Feature Of Series A Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureOfSeriesAConvertiblePreferredStock
44000
nwbo Adjustments To Additional Paid In Capital Beneficial Conversion Feature Of Series A Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureOfSeriesAConvertiblePreferredStock
0
nwbo Capital Expenditures Included In Accounts Payable And Accrued Expenses To Related Parties And Affiliates
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpensesToRelatedPartiesAndAffiliates
1294000
nwbo Capital Expenditures Included In Accounts Payable And Accrued Expenses To Related Parties And Affiliates
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpensesToRelatedPartiesAndAffiliates
710000
nwbo Capital Expenditures Included In Accounts Payable
CapitalExpendituresIncludedInAccountsPayable
954000
nwbo Capital Expenditures Included In Accounts Payable
CapitalExpendituresIncludedInAccountsPayable
0
nwbo Conversion Of Outstanding Accounts Payables To Note Payable And Contingent Payable
ConversionOfOutstandingAccountsPayablesToNotePayableAndContingentPayable
0
nwbo Conversion Of Outstanding Accounts Payables To Note Payable And Contingent Payable
ConversionOfOutstandingAccountsPayablesToNotePayableAndContingentPayable
8560000
nwbo Issuance Of Common Shares In With Connection Settlement Agreement
IssuanceOfCommonSharesInWithConnectionSettlementAgreement
0
nwbo Issuance Of Common Shares In With Connection Settlement Agreement
IssuanceOfCommonSharesInWithConnectionSettlementAgreement
12000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include recoverability and useful lives (indefinite) of intangible asset, assessment of impairment of goodwill, valuing equity securities in share-based payment arrangements, estimating the fair value of financial instruments recorded as derivative liabilities, useful lives of depreciable assets and whether impairment charges may apply.</p>
CY2020Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
194391000
CY2020Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2857000
CY2020Q3 nwbo Contingent Payable Derivative Liability
ContingentPayableDerivativeLiability
7384000
CY2020Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
204632000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
20213000
CY2019Q4 nwbo Contingent Payable Derivative Liability
ContingentPayableDerivativeLiability
7261000
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
27474000
CY2020Q3 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
2010000.00
CY2020Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
200000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38908000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
572000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39307000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1563000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
26800000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
104659
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.24
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
203600
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.25
nwbo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
4250
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.22
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
304009
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y2M12D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
160717
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
206232
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
109819
CY2020Q2 nwbo Share Based Compensation Arrangement By Share Based Payment Award Number Of Stock Options Agreed Not To Be Exercised By Holder
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfStockOptionsAgreedNotToBeExercisedByHolder
39200000
CY2020Q2 nwbo Share Based Compensation Arrangement By Share Based Payment Award Period During Which Stock Options Agreed Not To Be Exercised By Holder
ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodDuringWhichStockOptionsAgreedNotToBeExercisedByHolder
P6M
CY2020Q2 nwbo Share Based Compensation Arrangement By Share Based Payment Award Stock Option Extended Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionExtendedContractualTerm
P6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
78000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1750000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3000000
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.22
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
300000
CY2020Q3 nwbo Constructions In Progress Net
ConstructionsInProgressNet
7135000
CY2019Q4 nwbo Constructions In Progress Net
ConstructionsInProgressNet
1685000
CY2020Q3 us-gaap Depreciation
Depreciation
17000
CY2019Q3 us-gaap Depreciation
Depreciation
8000
us-gaap Depreciation
Depreciation
33000
us-gaap Depreciation
Depreciation
16000
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
16961000
CY2020Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
944000
CY2020Q3 nwbo Fair Value Of Embedded Conversion Option
FairValueOfEmbeddedConversionOption
2857000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
18874000
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
13411000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
688000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
12723000
CY2020Q3 nwbo Interest Expense Related To Forbearance Of Debt
InterestExpenseRelatedToForbearanceOfDebt
4270000
nwbo Interest Expense Related To Forbearance Of Debt
InterestExpenseRelatedToForbearanceOfDebt
4270000
CY2019Q3 us-gaap Interest Expense Other
InterestExpenseOther
1000
us-gaap Interest Expense Other
InterestExpenseOther
8000
us-gaap Interest Expense Other
InterestExpenseOther
2000
CY2020Q3 us-gaap Interest Expense
InterestExpense
5540000
CY2019Q3 us-gaap Interest Expense
InterestExpense
724000
us-gaap Interest Expense
InterestExpense
7224000
us-gaap Interest Expense
InterestExpense
2267000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
662000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
456726000
nwbo Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
63357
nwbo Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
0.0031
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
341798
CY2020Q3 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.25
nwbo Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
P1Y9M18D
CY2020Q3 us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
8000
CY2019Q3 us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
36000
us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
19000
us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
364000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
122000
CY2020Q3 nwbo Interest Expense Related To Forbearance Of Debt
InterestExpenseRelatedToForbearanceOfDebt
4270000
nwbo Interest Expense Related To Forbearance Of Debt
InterestExpenseRelatedToForbearanceOfDebt
4270000
CY2020Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
4278000
CY2019Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
36000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
4411000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
364000
CY2020Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8500000
CY2020Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P2Y
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
nwbo Fair Value Issuance Of New Warrants
FairValueIssuanceOfNewWarrants
1000000.0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2020Q3 nwbo Class Of Warrant Or Right Agreed To Be Suspended
ClassOfWarrantOrRightAgreedToBeSuspended
14600000
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
359473
CY2019Q4 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.27
CY2019 nwbo Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
P1Y5M1D
nwbo Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
80809
nwbo Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
0.24
nwbo Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
34746
nwbo Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
0.28
nwbo Number Of Warrants Warrants Cashless Exercise
NumberOfWarrantsWarrantsCashlessExercise
381
nwbo Weighted Average Exercise Price Warrants Cashless Exercise
WeightedAverageExercisePriceWarrantsCashlessExercise
0.26
CY2020Q2 nwbo Class Of Warrant Or Right Percentage Of Warrants Issued On Conversion
ClassOfWarrantOrRightPercentageOfWarrantsIssuedOnConversion
0.175
CY2020Q2 nwbo Class Of Warrant Or Right Suspended
ClassOfWarrantOrRightSuspended
81000000
CY2020Q2 nwbo Class Of Warrant Or Right Agreed To Be Suspended
ClassOfWarrantOrRightAgreedToBeSuspended
14200000
CY2020Q2 nwbo Class Of Warrant Or Right Agreed To Be Suspended And Unexercisable
ClassOfWarrantOrRightAgreedToBeSuspendedAndUnexercisable
90000000
CY2020Q2 nwbo Class Of Warrant Or Right Whose Exercise Period Is Extended
ClassOfWarrantOrRightWhoseExercisePeriodIsExtended
29000000
CY2020Q2 nwbo Class Of Warrant Or Right Whose Exercise Period Is Extended
ClassOfWarrantOrRightWhoseExercisePeriodIsExtended
29000000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9600000
nwbo Stock Issued During Period Shares Warrant Exercises
StockIssuedDuringPeriodSharesWarrantExercises
34700000
CY2020Q3 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4900000
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P20Y
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4300000
us-gaap Operating Lease Cost
OperatingLeaseCost
700000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
33000
us-gaap Variable Lease Cost
VariableLeaseCost
61000
us-gaap Lease Cost
LeaseCost
794000
us-gaap Operating Lease Payments
OperatingLeasePayments
745000
us-gaap Operating Lease Cost
OperatingLeaseCost
619000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
119000
us-gaap Variable Lease Cost
VariableLeaseCost
11000
us-gaap Lease Cost
LeaseCost
749000
us-gaap Operating Lease Payments
OperatingLeasePayments
162000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
328000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
728000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
644000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
644000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
644000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
8990000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11978000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7081000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4897000
CY2019Q4 nwbo Constructions In Progress Net
ConstructionsInProgressNet
1685000
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
7443000
CY2019Q4 us-gaap Assets
Assets
10643000
CY2019Q4 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
3844000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44196000
CY2019Q4 us-gaap Liabilities
Liabilities
55698000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-841395000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-45055000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10643000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3538000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10092000
CY2019Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7178000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
22760000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6585000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21247000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-6371000
us-gaap Net Income Loss
NetIncomeLoss
-27357000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5479000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26334000
us-gaap Net Income Loss
NetIncomeLoss
-27357000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-3412000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25881000
nwbo Capital Expenditures Included In Accounts Payable And Accrued Expenses To Related Parties And Affiliates
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpensesToRelatedPartiesAndAffiliates
710000
CY2020Q2 nwbo Class Of Warrant Or Right Suspended And Unexercisable
ClassOfWarrantOrRightSuspendedAndUnexercisable
171000000
CY2020Q2 nwbo Class Of Warrant Or Right Suspended And Unexercisable
ClassOfWarrantOrRightSuspendedAndUnexercisable
171000000
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5000000

Files In Submission

Name View Source Status
0001104659-21-004396-index-headers.html Edgar Link pending
0001104659-21-004396-index.html Edgar Link pending
0001104659-21-004396.txt Edgar Link pending
0001104659-21-004396-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nwbo-20200930.xsd Edgar Link pending
nwbo-20200930x10q.htm Edgar Link pending
nwbo-20200930x10q_htm.xml Edgar Link completed
nwbo-20200930xex31d1.htm Edgar Link pending
nwbo-20200930xex32d1.htm Edgar Link pending
nwbo-20200930_cal.xml Edgar Link unprocessable
nwbo-20200930_def.xml Edgar Link unprocessable
nwbo-20200930_lab.xml Edgar Link unprocessable
nwbo-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending